Ye Min, Liu Shwu-Huey, Jiang Zaoli, Lee Yashang, Tilton Robert, Cheng Yung-Chi
Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
Rapid Commun Mass Spectrom. 2007;21(22):3593-607. doi: 10.1002/rcm.2832.
PHY906 is a Chinese medicine formulation prepared from four medicinal herbs for adjuvant cancer chemotherapy. In this paper, liquid chromatography/electrospray ionization time-of-flight mass spectrometry (LC/ESI-TOFMS) was used to clarify the chemical composition of PHY906. The aqueous extract of PHY906 was separated on a Waters Atlantis C(18) column, and was eluted with acetonitrile/0.05% (v/v) formic acid. The separated compounds were identified with pure standards, or tentatively characterized by analyzing their mass spectra recorded in both negative and positive ion polarity modes. Further structural information was obtained from in-source fragmentation. Based on the LC/MS analysis, we proposed the structures for 64 bioactive compounds, including flavonoids, triterpene saponins, and monoterpene glycosides. All the compounds identified from PHY906 were further assigned in the four individual herbs, and some of them are reported for the first time.
PHY906是一种由四种草药制成的用于癌症化疗辅助治疗的中药制剂。本文采用液相色谱/电喷雾电离飞行时间质谱(LC/ESI-TOFMS)来阐明PHY906的化学成分。PHY906的水提取物在Waters Atlantis C(18)柱上进行分离,并用乙腈/0.05%(v/v)甲酸洗脱。分离出的化合物通过纯标准品进行鉴定,或通过分析在负离子和正离子极性模式下记录的质谱图进行初步表征。从源内裂解获得了进一步的结构信息。基于LC/MS分析,我们提出了64种生物活性化合物的结构,包括黄酮类、三萜皂苷和单萜糖苷。从PHY906中鉴定出的所有化合物都进一步在四种单一草药中进行了归属,其中一些是首次报道。